Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Name: Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study
SKU: 2882
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 1 Articles Tags: attention-deficit-disorder-with-hyperactivity, chronic, fatigue-syndrome, fibromyalgia, joel-l-young, judith-c-redmond, myofascial-pain-syndromes, pain, psychopharmacology, psychotropic-drugs

Description

Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Description

Joel L. Young, MD

COMPLICATED CASE HISTORIES

Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Joel L. Young, MD and Judith C. Redmond, MA

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder

Philip T. Ninan, MD: Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment

Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Description

Joel L. Young, MD

COMPLICATED CASE HISTORIES

Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Joel L. Young, MD and Judith C. Redmond, MA

Related products

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder

Philip T. Ninan, MD: Generalized Anxiety Disorder: Diagnosis, Neurobiology, and Treatment